FDA Determines Regulatory Review Period for TOTAL POSTERIOR SPINE SYSTEM (TOPS SYSTEM) Patent Extension

Summary

The Food and Drug Administration (FDA) has determined the regulatory review period for TOTAL POSTERIOR SPINE SYSTEM (TOPS SYSTEM) patent extension following submissions to the US Patent and Trademark Office (USPTO) for patent extension, as required by law.